Product Images Propofol

This text provides information about target plasma concentration levels and recovery times after different lengths of infusions. It also includes a graph showing awakening and minutes after the end of the infusion.*

This text provides information about a medication called propofol injectable emulsion USP, used for general anesthesia. It includes details on dosage, composition, administration guidelines, storage instructions, and precautions. The medication should only be administered by trained personnel, and continuous monitoring of patients is recommended. Strict aseptic techniques are advised, and the medication contains ingredients that inhibit microbial growth. Additionally, it mentions the necessity of having facilities for airway maintenance and oxygen enrichment readily available.*

This is a description of Propofol Injectable Emulsion, USP, with a concentration of 10 mg per mL. It is indicated for intravenous administration and is for single-patient use only. The product should be stored between 4°C to 25°C (40°F to 77°F) and needs to be shaken well before use. The solution is sterile, nonpyrogenic, and contains components such as propofol, soybean oil, glycerol, egg phospholipids, disodium edetate, and sodium hydroxide to adjust pH. The dosage information should be followed as per the package insert, and strict aseptic techniques are recommended. The product contains EDTA, which inhibits microbial growth for up to 12 hours, and if opened, should be discarded within 12 hours. It is important not to freeze the product. The manufacturing license number is G/28/1751, and it is made in India by Amneal Pharmaceuticals LG, based in Bridgewater, NJ.*

This text appears to be a medication label for a 100 mL vial of Propofol injectable emulsion, USP. It is intended for single-patient use and should not be frozen. The content includes ingredients such as EDTA, soybean oil, glycerol, phospholipids, and sodium hydroxide. The emulsion inhibits microbial growth and should be used within 12 hours of opening. The dosage is 10mg per mL for intravenous administration. The product is sterile, nonpyrogenic, and manufactured in India. It is distributed by Amneal Pharmaceuticals in Bridgewater, NJ.*

This text provides detailed information about Propofol injectable emulsion USP, a medication used for intravenous administration during procedures requiring general anesthesia. The description includes dosage information, ingredients, storage instructions, administration guidelines, and monitoring requirements. It emphasizes the importance of proper training for administration, continuous patient monitoring, and the availability of emergency equipment. Additionally, it mentions the pharmaceutical company manufacturing the medication and provides guidelines for aseptic technique and microbial growth inhibition. The text also includes important safety warnings and a directive to discard the medication within 12 hours of opening due to the presence of EDTA.*